ACS GCI Pharmaceutical Roundtable

Awards

2024 Awards

Congratulations to the 2024 GCIPR Award Winners!

Inaugural Data Science and Modeling for Green Chemistry Award

Bristol-Meyers Squibb
“PMI Prediction and Bayesian Optimization: Two Tools with One Goal Towards the Development of ‘Greener-by-Design’ Synthesis of APIs”
Read more about BMS’s innovation.

 

2024 CMO Excellence in Green Chemistry Award

PharmaBlock
“Sustainable Manufacturing Process for Commercial and Developmental Stage Intermediates through Two Consecutive Flow Reactions using Micro-packed Bed Technology”

 

2024 Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry Awards

GSK
“Development of a More Sustainable 2nd Generation Route to Peptide-Maleimidocaproyl MonoMethyl Auristatin F (mcMMAF)-the Cytotoxic Payload for Blenrep®, A Novel Antibody Conjugate Drug (ACD) for the Treatment of Multiple Myeloma”

Boehringer Ingelheim
“Development of a short and eco-friendly asymmetric manufacturing process for Spiroketone CD 7659”


Award Program Information

Data Science and Modeling for Green Chemistry

Description

The Data Science and Modeling for Green Chemistry award aims to recognize the research and development of computational tools that guide the design of sustainable chemical processes and the execution of green chemistry that demonstrates compelling environmental, safety, and efficiency improvements over current technologies in the pharmaceutical industry and its allied industrial partners.

The award will be publicly presented at the ACS Green Chemistry Institute’s Green Chemistry & Engineering Conference. The recipient, or a member of the winning team, will be invited to share their technology in an oral presentation at this event. The speaker’s transportation, lodging and registration fees for the conference are reimbursable up to $2,500 USD (additional funds available for international travel following ACS guidelines). The recipient or winning team will also receive a plaque recognizing the achievement and certificates will be given to each team member.

Eligibility

The computational invention can take the form of algorithms and/or software tools. All inventions that leverage machine learning, data science, and/or other computational modeling techniques are in scope. Submissions should both highlight the technological breakthrough and show how the tool is specifically designed for end-users to drive towards greener processes (see selection criteria). Both academic and industrial research groups are eligible. Nominees do not have to be members of the American Chemical Society or the ACS GCIPR.

Application

Please use our online application portal to submit your application.

Applications will open in Fall 2024 for the 2025 award cycle.

To use the portal, you will need to have or create a free ACS ID.

Please be prepared to submit the following information in the portal:

  • Contact information of nominator
  • Contact information of nominee(s)
  • Title of green chemistry technology
  • Focus area selection:
    • Predictive tools for designing greener or safer reagents, processing conditions, or reaction outcomes
    • AI platform technologies that have wide application across the pharmaceutical industry or have been used in the development of a drug on significant scale
    • In silico approaches that minimize/reduce experimentation to arrive at superior reaction conditions
  • Abstract (300 words) – Describe the technology, the problem it addresses, and its benefits regarding the Design Principles of Green Chemistry and engineering. Include the degree of implementation and transferability to manufacturing. Also, include any quantitative benefits such as the (potential) amounts of hazardous substances eliminated, energy saved, carbon dioxide emissions eliminated, and water saved.
  • Detailed description (max 3 pages) – The judges will evaluate the problem, chemistry, and realized or potential benefits.
    • Problem. Describe the challenges that existed prior to application of the new technology.
    • Chemistry. Describe the scientific merits of the new computer-assisted technology, emphasizing novelty, scientific merit and application to solve a challenging problem.
    • Potential or realized benefits. Detail the benefits to human health and environment by evaluation of your technology against the Design Principles of Green Chemistry, such as reduced toxicity of process materials, more reactive or sustainable catalyst design, minimization of experiments, reduction to PMI, optimization of yield/selectivity or similar benefit.
  • References

Selection Criteria

  1. Innovation and Novelty: The tool should demonstrate a high degree of innovation in implementing computational and modeling techniques for designing environmentally friendly processes in pharmaceutical manufacturing.
  2. Environmental Impact: The tool should effectively address and mitigate environmental impacts associated with pharmaceutical production, such as reducing waste generation, carbon emissions, water usage, and energy consumption.
  3. Efficiency and Cost-Effectiveness: The tool should provide resource-efficient solutions, thereby reducing costs associated with green manufacturing practices. It should demonstrate the ability to improve process efficiency and optimize resource utilization.
  4. Safety and Toxicity Prediction: The tool should incorporate accurate predictive models to assess the safety and toxicity profiles of chemical reactions, helping in the identification and design of less hazardous or non-toxic compounds.
  5. Versatility and Applicability: The tool should be applicable to a wide range of chemical reactions or processes within pharmaceutical manufacturing, ensuring its versatility for various green chemistry challenges.
  6. Integration with Other Tools/Software: The tool should have the potential to seamlessly integrate with other in silico tools or software commonly used in pharmaceutical manufacturing, enhancing its overall utility and interoperability.
  7. User-Friendly and Intuitive Interface: The tool should have a user-friendly interface, ensuring ease-of-use and accessibility to a broader audience, including researchers, process chemists, and other stakeholders.
  8. Validation and Reliability: The tool should have a strong validation framework, demonstrating reliable and accurate results through comparison with experimental data or benchmark studies.
  9. Openness and Availability: The tool should have an open-source or commercially available license that allows easy access and promotes collaboration, thus benefiting the broader scientific community.
  10. Proven Impact and Success Stories: The tool should showcase successful case studies or testimonials that highlight its positive impact on reducing the environmental footprint and improving sustainability in pharmaceutical manufacturing.

Judging

A panel of industrial pharmaceutical scientists will evaluate the applications and recommend a winner. Notifications will go out in early 2025.

CMO Excellence in Green Chemistry Award

Description

The CMO Excellence in Green Chemistry Award seeks to recognize outstanding efforts by CMO companies in pharmaceutical green chemistry in support of pharmaceutical research, development and manufacturing that demonstrate compelling environmental, safety and/or efficiency improvements.

The award intends to recognize greener advances in synthetic route development for starting materials, intermediates or active pharmaceutical ingredients (APIs), including reaction conditions and chemical or manufacturing technologies.

The submission should highlight the green and sustainable chemistry accomplishments at meaningful scale and must detail their significance (e.g., reduction in process mass intensity, improvement in RPG (iGAL), waste reduction, robustness, environmental, health and safety impact reduction or elimination, reduction in the use of toxic and/or hazardous chemicals, solvents, reagents, etc.).

The award will be publicly presented at the ACS Green Chemistry Institute’s Green Chemistry & Engineering Conference. The recipient, or a member of the winning team, will be invited to share their technology in an oral presentation at this event. The speaker’s transportation, lodging and registration fees for the conference are reimbursable up to $2,500 USD (additional funds available for international travel following ACS guidelines). The option to present virtually is also available this year. The recipient or winning team will also receive a plaque recognizing the achievement and certificates will be given to each team member.

Chemistry enhances the quality of life and green chemistry is the path to enhanced global sustainability while delivering these benefits. The ACS GCIPR looks forward to receiving submissions for consideration for the CMO Excellence in Green Chemistry Award.

Eligibility

Accomplishments relative to the design principles of green chemistry at meaningful scale are eligible for this award. Nominations must detail the significance (i.e., in yield, waste reduction, greenness (RPG), robustness, environmental impact, reduction of toxic and/or hazardous chemicals, etc.) of the chemistry or engineering.

The CMO Excellence in Green Chemistry Award seeks to recognize CMO company-level accomplishments that highlight a strategic commitment to green chemistry and engineering innovation and to greater industrial sustainability.

Nominees do not have to be members of the American Chemical Society nor the ACS GCIPR.

Application

Please use our online application portal to submit your application.

Applications will open in Fall 2024 for the 2025 award cycle.

A panel of industrial pharmaceutical scientists will evaluate the applications and recommend a winner. Notifications will go out in early 2024.

Chemistry enhances lives across the globe and green chemistry is the path to enhanced sustainability. The ACS GCIPR looks forward to receiving your submission to be considered as the best at pharmaceutical green chemistry development.

Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry

Description

The Peter J. Dunn Award was established in 2016 by the ACS GCI Pharmaceutical Roundtable (ACS GCIPR) to recognize excellence in the research, development and execution of green chemistry that demonstrates compelling environmental, safety and efficiency improvements over current technologies in the pharmaceutical industry and its allied industrial partners. The inaugural award was given to Peter J. Dunn of Pfizer, and the award was subsequently named in his honor.

The award recognizes greener and more sustainable synthetic routes and their associated processes to Active Pharmaceutical Ingredients (APIs) or intermediates, reaction conditions, and chemical or manufacturing process technologies.

The submission should highlight the green and sustainable chemistry accomplishments at meaningful scale and must detail their significance (e.g., reduction in process mass intensity, waste reduction, robustness, environmental, health and safety impact reduction or elimination, reduction in the use of toxic and/or hazardous chemicals, solvents, reagents, etc.). The innovations should be significant and ones that go beyond routine process development optimization.

The award will be presented at the Green Chemistry & Engineering Conference. The recipient, or a member of the winning team, will be invited to share their technology in an oral presentation at this event. The recipient’s transportation, lodging and registration fees for the conference are reimbursable up to $2,500 USD (additional funds available for international travel following ACS guidelines). The recipient or winning team will also receive a plaque recognizing the achievement and certificates will be given to each team member.

Eligibility

New accomplishments relative to the design principles of green chemistry at meaningful scale are eligible for this award. Nominations must detail the significance (i.e., in yield, waste reduction, robustness, environmental impact, reduction of toxic and/or hazardous chemicals, etc.) of the chemistry or engineering.

The Peter J. Dunn Award recognizes the accomplishments of individuals—whether they be individual contributions or as part of team efforts. Therefore, the ACS GCIPR strongly encourages individuals to apply. However, please note that this is not a career achievement award, rather the focus is on a specific innovative technology developed by the nominee. Nominations may also include teams of up to ten people.

The goal is to recognize both pioneering industrial scientists, as well as the best of green chemistry innovations, to inspire all pharmaceutical scientists (or allied industrial partners) to ever greater sustainability.

Note: Previous winning submissions from the EPA Green Chemistry Challenge Award are not eligible.

Application

Please use our online application portal to submit your application.

Applications will open in Fall 2024 for the 2025 award cycle.

Examples of Successful Submissions:

A panel of industry peers will evaluate the applications.

Chemistry enhances lives across the globe and green chemistry is the path to enhanced sustainability. The ACS GCIPR looks forward to receiving your submission to be considered as the best at pharmaceutical green chemistry development.


Past Winners

 

CMO Excellence in Green Chemistry

2022

PharmaBlock Sciences from Nanjing, China, received the CMO Award for their “Innovative Continuous Process for the Production of 3-Oxocyclobutane-1-Carboxylic Acid”

The inaugural CMO Excellence in Green Chemistry Award goes to Asymchem, located in Tianjin, China, for “Leveraging innovative manufacturing technologies to deliver sustainable processes: A production-scale continuous [2 + 2] photocycloaddition to prepare a key raw material.”

 

Pete Dunn Award

2023

Bristol-Myers Squibb was awarded for “Sustainable Manufacturing of BMS-986278 Leveraging an ERED/KRED Biocatalytic Cascade.”

Merck was awarded for “Greener Manufacturing of STING agonist (MK-1454) featuring a Kinase-cGAS enzymatic cascade.”

2022

Karla Camacho Soto, Mike DiMaso, Jacob Forstater, Nadine Kuhl, Reed Larson, Chris Prier, and Ben Turnbull, Merck
“From wood pulp to a candidate medicine: Green manufacturing technologies enable the production of investigational leukemia drug nemtabrutinib from a biorenewable commodity material.”

2021

Stephen Dalby, François Lévesque, Cecilia Bottecchia and Jonathan McMullen, Merck
“Greener Manufacturing of Belzutifan (MK-6482) Featuring a Photo-Flow Bromination.”

2020

Dan Bailey, Takeda Pharmaceuticals
“Beyond Organic Solvents: Synthesis of a 5-HT4 receptor agonist in water.”

2019

B. Frank Gupton, Floyd D. Gottwald Jr. Chair in Pharmaceutical Engineering at Virginia Commonwealth University
“Increasing Access to Global Health Care through Process Intensification.”

2017

Bruce Lipshutz, professor of chemistry and biochemistry at the University of California, Santa Barbara, and Sachin Handa, assistant professor of chemistry at the University of Louisville.
“Development of Newly Engineered Catalysts for Sustainable Surfactant Chemistry in Water.”

2016

Peter J. Dunn, Global Head of Green Chemistry, Pfizer

Copyright © 2019 ACS Green Chemistry Institute Pharmaceutical Roundtable